Showing results (441-450 of 468) with videos related to
Sort By:
Pageof 47
JAMA Oncology|August 4, 2018
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to OsimertinibGeoffrey R Oxnard, Yuebi Hu, Kathryn F Mileham, et al.The Lancet. Oncology|November 10, 2016
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trialJoel W Neal, Suzanne E Dahlberg, Heather A Wakelee, et al.Osteoarthritis and Cartilage|December 16, 2019
Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiativeR S Hinman, K D Allen, K L Bennell, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung CancerNathan R Foster, Lindsay A Renfro, Steven E Schild, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxaneElly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|August 31, 2013
Serial femtosecond X-ray diffraction of 30S ribosomal subunit microcrystals in liquid suspension at ambient temperature using an X-ray free-electron laserHasan Demirci, Raymond G Sierra, Hartawan Laksmono, et al.Cancer Medicine|August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trialLaurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.Cancer|September 17, 2013
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervixAlexi A Wright, Brooke E Howitt, Andrea P Myers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2019
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508Suresh S Ramalingam, Suzanne E Dahlberg, Chandra P Belani, et al.Blood Advances|August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populationsPaul A Carpenter, Ted A Gooley, Julie Boiko, et al.Pageof 47